Increased epitope-specific CD8+ T cells prevent murine coronavirus spread to the spinal cord and subsequent demyelination.
CD8+ T cells are important for clearance of neurotropic mouse hepatitis virus (MHV) strain A59, although their possible role in A59-induced demyelination is not well understood. We developed an adoptive-transfer model to more clearly elucidate the role of virus-specific CD8+ T cells during the acute and chronic phases of infection with A59 that is described as follows. C57BL/6 mice were infected with a recombinant A59 virus expressing the gp33 epitope, an H-2Db-restricted CD8+ T-cell epitope encoded in the glycoprotein of lymphocytic choriomeningitis virus, as a fusion with the enhanced green fluorescent protein (RA59-gfp/gp33). P14 splenocytes (transgenic for a T-cell receptor specific for the gp33 epitope) were transferred at different times pre- and postinfection (p.i.). Adoptive transfer of P14 splenocytes 1 day prior to infection with RA59-gfp/gp33, but not control virus lacking the gp33 epitope, RA59-gfp, reduced weight loss and viral replication and spread in the brain and to the spinal cord. Furthermore, demyelination was significantly reduced compared to that in nonrecipients. However, when P14 cells were transferred on day 3 or 5 p.i., no difference in acute or chronic disease was observed compared to that in nonrecipients. Protection in mice receiving P14 splenocytes prior to infection correlated with a robust gp33-specific immune response that was not observed in mice receiving the later transfers. Thus, an early robust CD8+ T-cell response was necessary to reduce virus replication and spread, specifically to the spinal cord, which protected against demyelination in the chronic phase of the disease.
MacNamara
Katherine C
KC
Department of Microbiology, University of Pennsylvania, School of Medicine, 36th St. and Hamilton Walk, Philadelphia, PA 19104-6076, USA.
Chua
Ming Ming
MM
Nelson
Peter T
PT
Shen
Hao
H
Weiss
Susan R
SR
D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D017934:Coronavirus / Q000254:growth & development / Q000276:immunology*; D018352:Coronavirus Infections / Q000276:immunology* / Q000821:virology; D003711:Demyelinating Diseases / Q000517:prevention & control*; D004195:Disease Models, Animal; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D013116:Spinal Cord / Q000473:pathology / Q000821:virology*; D010948:Viral Plaque Assay
D018984:Epitopes, T-Lymphocyte
J Immunol. 1999 Dec 1;163(11):6106-13
10570300
J Immunol. 1999 Sep 15;163(6):3379-87
10477608
J Immunol. 2000 Aug 15;165(4):2278-86
10925317
J Virol. 2000 Sep;74(17):7903-10
10933698
Virology. 2001 Oct 25;289(2):230-8
11689046
Nat Immunol. 2002 Mar;3(3):265-71
11828323
J Neurovirol. 2002 Jun;8(3):257-64
12053280
J Immunol. 2002 Aug 1;169(3):1550-5
12133983
Virology. 2002 Sep 15;301(1):109-20
12359451
J Neurovirol. 2002 Oct;8(5):381-91
12402164
Int Immunol. 2003 Jan;15(1):119-25
12502732
J Virol. 2003 Feb;77(4):2775-8
12552021
Immunity. 2003 Apr;18(4):499-511
12705853
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
Virology. 2003 Aug 1;312(2):369-80
12919742
J Virol. 2004 Feb;78(3):1150-9
14722270
Adv Immunol. 1980;30:275-331
6160740
Lab Invest. 1988 Jan;58(1):31-6
2826881
J Virol. 1989 Jul;63(7):3051-6
2542613
Virology. 1989 Jun;170(2):556-60
2543129
J Neuroimmunol. 1990 Nov;30(1):31-41
2172304
Eur J Immunol. 1991 Sep;21(9):2195-202
1716213
Virology. 1994 Apr;200(1):1-10
8128613
Adv Exp Med Biol. 1993;342:327-32
7516107
J Immunol. 1994 Jul 15;153(2):818-23
7912707
J Virol. 1995 Feb;69(2):684-94
7815531
Microb Pathog. 1995 Mar;18(3):211-21
7565015
J Neurovirol. 1996 Dec;2(6):361-76
8972418
J Neurovirol. 1997 Jun;3(3):225-8
9200070
Immunity. 1998 Feb;8(2):177-87
9491999
J Immunol. 1998 Mar 15;160(6):2896-904
9510193
J Exp Med. 1998 May 18;187(10):1575-82
9584136
Adv Exp Med Biol. 1998;440:425-30
9782310
J Immunol. 1999 Feb 1;162(3):1641-7
9973424
J Immunol. 2000 Apr 15;164(8):4080-8
10754301